| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 167.05B | 166.70B | 141.10B | 52.90B | 74.53B |
| Gross Profit | 1.70B | 8.51B | 7.09B | -29.91B | -11.31B |
| EBITDA | 24.98B | 33.90B | 32.40B | -18.16B | 4.61B |
| Net Income | -1.74B | -237.31M | -1.05B | -45.18B | -18.83B |
Balance Sheet | |||||
| Total Assets | 343.16B | 345.77B | 335.30B | 295.01B | 298.42B |
| Cash, Cash Equivalents and Short-Term Investments | 16.02B | 22.51B | 15.63B | 11.44B | 16.71B |
| Total Debt | 232.43B | 226.70B | 175.39B | 214.18B | 182.87B |
| Total Liabilities | 303.95B | 304.82B | 300.01B | 273.45B | 232.55B |
| Stockholders Equity | 42.53B | 45.15B | 37.23B | 23.61B | 61.40B |
Cash Flow | |||||
| Free Cash Flow | 24.48B | 14.44B | 12.65B | -24.40B | 6.81B |
| Operating Cash Flow | 42.05B | 34.55B | 35.42B | -16.76B | 12.89B |
| Investing Cash Flow | -15.08B | -17.86B | -15.25B | -6.87B | -4.45B |
| Financing Cash Flow | -33.65B | -10.56B | -15.85B | 18.10B | 1.71B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | HK$69.39B | 7.51 | 19.38% | 5.38% | 8.54% | 16.57% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
47 Neutral | HK$105.69B | 113.91 | -6.44% | ― | 1.42% | 3.33% | |
44 Neutral | HK$101.44B | -43.52 | -7.13% | ― | 4.61% | 38.36% | |
43 Neutral | HK$121.23B | -60.78 | -4.06% | ― | 4.08% | ― |